newsfilter
← Latest News
PR Newswire·

BioLineRx to Report First Quarter 2024 Results on May 28, 2024

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...